Frances M. Palmieri

Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)

Vivek Roy, Betsy LaPlant, Gerald G. Gross et al. · Annals of Oncology · 2008 · 144 citations · Full text

Metastatic Breast Cancer, Breast Oncology, Phase Ii Trial +8

Prognosis and Outcome of Small (≤1 cm), Node-Negative Breast Cancer on the Basis of Hormonal and HER-2 Status

Surabhi Amar, Ann E. McCullough, Winston Tan et al. · The Oncologist · 2010 · 44 citations · Full text

North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer

Edith A. Perez, David W. Hillman, Todor Dentchev et al. · Annals of Oncology · 2009 · 44 citations · Full text

Metastatic Breast Cancer, Breast Oncology, Phase Ii Trial +7

Comprehensive Diagnostic Program for Medically Underserved Women With Abnormal Breast Screening Evaluations in an Urban Population

Frances M. Palmieri, Elizabeth R. DePeri, Betty A. Mincey et al. · Mayo Clinic Proceedings · 2009 · 36 citations · Full text

Cancer Detection, Cancer Screening, Urban Population +8

Anthracycline vs nonanthracycline adjuvant therapy for breast cancer.

Dina K. Tack, Frances M. Palmieri, Edith A. Perez · PubMed · 2004 · 20 citations

Surgical Oncology, Oncology, Breast Cancer Research +9